Zhiqiao Xu

机构：Zhejiang Cancer Hospital, Anshan Hospital · ORCID：0000-0003-3039-762X

发表论文 28 篇 · 总被引 378 次 · h-index 10

代表论文

• Circular RNA hsa_circ_0000654 promotes esophageal squamous cell carcinoma progression by regulating the miR‐149‐5p/IL‐6/STAT3 pathway (2019 · IUBMB Life · 被引 73)
• CircRNA_001569 promotes cell proliferation through absorbing miR-145 in gastric cancer (2018 · The Journal of Biochemistry · 被引 64)
• Efficacy and safety of lapatinib and trastuzumab for HER2-positive breast cancer: a systematic review and meta-analysis of randomised controlled trials (2017 · BMJ Open · 被引 64)
• Overexpression of HOTAIR leads to radioresistance of human cervical cancer via promoting HIF-1α expression (2018 · Radiation Oncology · 被引 63)
• Combined Treatment with Autologous CIK Cells, Radiotherapy and Chemotherapy in Advanced Cervical Cancer (2018 · Pathology & Oncology Research · 被引 21)
• Comparison of concurrent chemoradiotherapy with radiotherapy alone for locally advanced esophageal squamous cell cancer in elderly patients: A randomized, multicenter, phase II clinical trial (2022 · International Journal of Cancer · 被引 19)